Showing 121 - 140 results of 232 for search '"cannabis"', query time: 0.06s Refine Results
  1. 121

    Cannabis sativa extracts inhibit LDL oxidation and the formation of foam cells in vitro, acting as potential multi-step inhibitors of atherosclerosis development. by Bruno Musetti, Alejandra Kun, David Menchaca, Alejandra Rodríguez-Haralambides, Javier Varela, Leonor Thomson, Edward M Bahnson

    Published 2024-01-01
    “…The three cannabis extracts inhibited the oxidation of LDL by copper ions and the formation of foam cells by J774.1 cells challenged with oxLDL (ED50 5-12 μg mL-1). …”
    Get full text
    Article
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127

    Quantification and prediction of human fetal (-)-Δ9-tetrahydrocannabinol/(±)-11-OH-Δ9-tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity by Aditya R. Kumar, Lyndsey S. Benson, Erica M. Wymore, Jocelyn E. Phipers, Jennifer C. Dempsey, Lucinda A. Cort, Jashvant D. Unadkat

    Published 2025-01-01
    “…Abstract Prenatal cannabis use is associated with neurodevelopmental deficits, likely due to exposure to the psychoactive cannabinoid, (-)-Δ9-tetrahydrocannabinol, and its active metabolite, (±)-11-OH-Δ9-tetrahydrocannabinol. …”
    Get full text
    Article
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132
  13. 133
  14. 134

    Evaluación de la solución nutritiva Steiner aplicada al cultivo de cáñamo medicinal (Cannabis sativa L.) var. Cherry Oregon, bajo invernadero by Michelle Arcos, Yamil Cartagena, Jorge Merino, Patricio Pérez Guerrero, Rafael Parra, Julio Moreno

    Published 2025-01-01
    “… El adecuado manejo nutricional es crucial para el desarrollo y producción de cannabinoides en el cultivo de Cannabis sativa var. Cherry Oregon. Esta investigación tuvo por objetivo evaluar el efecto de cinco concentraciones de solución nutritiva Steiner en la fenología del cáñamo medicinal, y determinar la dosis óptima de la solución nutritiva para el contenido de cannabinoides (cannabidiol [CBD] y tetrahidrocannabinol [THC]). …”
    Get full text
    Article
  15. 135

    Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol by A Eden Evins, Ellie Grossman, Julia Jashinski, Aurora Quaye, Corinne Cather, Kevin Potter, David A Schoenfeld, Jodi M Gilman

    Published 2022-06-01
    “…Participants will be randomly assigned in 1:1 ratio to use cannabis products, primarily from commercial cannabis dispensaries or to abstain from cannabis use for 6 months. …”
    Get full text
    Article
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140